Concord Drugs standalone net profit declines 33.33% in the September 2018 quarter
Sales rise 204.77% to Rs 11.49 crore
Net profit of Concord Drugs declined 33.33% to Rs 0.04 crore in the quarter ended September 2018 as against Rs 0.06 crore during the previous quarter ended September 2017. Sales rose 204.77% to Rs 11.49 crore in the quarter ended September 2018 as against Rs 3.77 crore during the previous quarter ended September 2017. ParticularsQuarter EndedSep. 2018Sep. 2017% Var.Sales11.493.77 205 OPM %8.4425.46 -PBDT0.600.66 -9 PBT0.050.09 -44 NP0.040.06 -33Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 23 2018 | 11:01 AM IST